应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MRK 默沙东
已收盘 06-24 16:00:00 EDT
120.60
+1.00
+0.84%
盘后
119.80
-0.80
-0.66%
19:55 EDT
最高
121.81
最低
119.51
成交量
1,048万
今开
120.90
昨收
119.60
日振幅
1.92%
总市值
2,993亿
流通市值
2,993亿
总股本
24.82亿
成交额
12.65亿
换手率
0.42%
流通股本
24.82亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
阿布扎比卫生部：携手默沙东共促运营卓越与区域医疗可及性
美股速递 · 03:12
阿布扎比卫生部：携手默沙东共促运营卓越与区域医疗可及性
默沙东(MRK)“K药”联合ADC疗法获欧盟批准 将用于膀胱癌成人患者治疗
金吾财讯 · 06-24 19:23
默沙东(MRK)“K药”联合ADC疗法获欧盟批准 将用于膀胱癌成人患者治疗
欧盟委员会批准Keytruda®（帕博利珠单抗）联合Padcev®（恩福妥单抗维多汀-ejfv）作为首个PD-1抑制剂联合抗体偶联药物治疗不适合顺铂的可切除非肌层浸润性膀胱癌成人患者
美股速递 · 06-24 18:46
欧盟委员会批准Keytruda®（帕博利珠单抗）联合Padcev®（恩福妥单抗维多汀-ejfv）作为首个PD-1抑制剂联合抗体偶联药物治疗不适合顺铂的可切除非肌层浸润性膀胱癌成人患者
异动解读｜默沙东盘中上涨3.03%，多重利好叠加催化股价走强
行情直击 · 06-24 01:19
异动解读｜默沙东盘中上涨3.03%，多重利好叠加催化股价走强
贝伦贝格上调默沙东目标价至125美元
中金财经 · 06-23 13:57
贝伦贝格上调默沙东目标价至125美元
默沙东Tulisokibart在3期Atlas-Uc诱导研究中达成主要及关键次要终点
美股速递 · 06-22 18:47
默沙东Tulisokibart在3期Atlas-Uc诱导研究中达成主要及关键次要终点
默沙东(MRK)肺炎球菌疫苗新增儿童适用人群 获批复盖2至17岁高危青少年
金吾财讯 · 06-18
默沙东(MRK)肺炎球菌疫苗新增儿童适用人群 获批复盖2至17岁高危青少年
异动解读｜默沙东盘中下跌3.01%，报111.97美元
行情直击 · 06-18
异动解读｜默沙东盘中下跌3.01%，报111.97美元
默沙东：在中国获批用于婴幼儿下呼吸道感染治疗
美股速递 · 06-15
默沙东：在中国获批用于婴幼儿下呼吸道感染治疗
默沙东(MRK)旗下默克动物保健收购动物农业科技创新企业TARGAN
金吾财讯 · 06-11
默沙东(MRK)旗下默克动物保健收购动物农业科技创新企业TARGAN
默沙东高管表示：我们关注更广泛的肥胖领域，但更聚焦于其并发症而非单纯肥胖
美股速递 · 06-09
默沙东高管表示：我们关注更广泛的肥胖领域，但更聚焦于其并发症而非单纯肥胖
默沙东高管表示：“国家授予恩利西肽的优先审评券正稳步推进”
美股速递 · 06-09
默沙东高管表示：“国家授予恩利西肽的优先审评券正稳步推进”
默沙东CEO于高盛医疗健康大会表示：公司将聚焦10亿至150亿美元并购“甜蜜点”
美股速递 · 06-09
默沙东CEO于高盛医疗健康大会表示：公司将聚焦10亿至150亿美元并购“甜蜜点”
默沙东(MRK.US)与吉利德科学(GILD.US)联合HIV药物三期临床试验达主要终点
智通财经 · 06-09
默沙东(MRK.US)与吉利德科学(GILD.US)联合HIV药物三期临床试验达主要终点
吉利德科学：Islatravir/Lenacapavir HIV治疗方案在两项试验中均达到第48周主要疗效终点
美股速递 · 06-09
吉利德科学：Islatravir/Lenacapavir HIV治疗方案在两项试验中均达到第48周主要疗效终点
吉利德科学：Trodelvy与Keytruda联用的安全性特征与各药物已知安全性一致
美股速递 · 06-09
吉利德科学：Trodelvy与Keytruda联用的安全性特征与各药物已知安全性一致
吉利德科学宣布终止Trodelvy联合Keytruda的III期Keynote-D46/Evoke-03研究
美股速递 · 06-09
吉利德科学宣布终止Trodelvy联合Keytruda的III期Keynote-D46/Evoke-03研究
默沙东欣瑞来重磅上市，填补针对肺动脉高压根源治疗空白
上观新闻 · 06-08
默沙东欣瑞来重磅上市，填补针对肺动脉高压根源治疗空白
异动解读｜默沙东盘中上涨3.44%，制药板块整体反弹叠加HIV新药获中国优先审评
行情直击 · 06-04
异动解读｜默沙东盘中上涨3.44%，制药板块整体反弹叠加HIV新药获中国优先审评
Apotex推出西格列汀片及西格列汀盐酸二甲双胍片，符合180天共享独占期资格
美股速递 · 06-03
Apotex推出西格列汀片及西格列汀盐酸二甲双胍片，符合180天共享独占期资格
加载更多
公司概况
公司名称：
默沙东
所属市场：
NYSE
上市日期：
--
主营业务：
默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。
发行价格：
--
{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":120.6,"timestamp":1782331200000,"preClose":119.6,"halted":0,"volume":10478132,"hourTrading":{"tag":"盘后","latestPrice":119.8,"preClose":120.6,"latestTime":"19:55 EDT","volume":1759184,"amount":212155272.9683,"timestamp":1782345325165,"change":-0.8,"changeRate":-0.006633,"amplitude":0.00738},"delay":0,"changeRate":0.008361204013377926,"floatShares":2482022536,"shares":2482022536,"eps":3.575809,"marketStatus":"已收盘","change":1,"latestTime":"06-24 16:00:00 EDT","open":120.9,"high":121.81,"low":119.51,"amount":1264639805.009,"amplitude":0.019231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.575809,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782374400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":119.6,"dividendRate":0.027197,"preHourTrading":{"tag":"盘前","latestPrice":120.35,"preClose":119.57,"latestTime":"09:29 EDT","volume":3374,"amount":403831.39454,"timestamp":1782307788563,"change":0.78,"changeRate":0.006523,"amplitude":0.018817},"postHourTrading":{"tag":"盘后","latestPrice":119.8,"preClose":120.6,"latestTime":"19:55 EDT","volume":1759184,"amount":212155272.9683,"timestamp":1782345325165,"change":-0.8,"changeRate":-0.006633,"amplitude":0.00738},"volumeRatio":0.731331,"impliedVol":0.2989,"impliedVolPercentile":0.3307},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"1102932036","title":"阿布扎比卫生部：携手默沙东共促运营卓越与区域医疗可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1102932036","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102932036?lang=zh_cn&edition=full","pubTime":"2026-06-25 03:12","pubTimestamp":1782328362,"startTime":"0","endTime":"0","summary":"阿布扎比卫生部与默沙东（MRK）达成战略合作，旨在推动医疗运营卓越性，并扩大该地区患者的医疗可及性。此次合作将整合双方资源与专长，以提升医疗服务质量与效率，惠及更广泛的社区。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","SG9999015358.SGD","IE0009355771.USD","LU0211331839.USD","LU1066051811.HKD","LU2433249047.HKD","LU0859254822.USD","LU0238689110.USD","LU2491050154.USD","LU0320765646.SGD","IE00BBT3K403.USD","LU0648001328.SGD","LU0985320562.USD","LU1699723380.USD","LU1989772923.USD","LU2125909247.SGD","BK4534","LU2023250843.SGD","LU1023059063.AUD","LU0965509283.SGD","LU2357627491.SGD","IE00BFTCPJ56.SGD","BK4516","LU0289739699.SGD","LU1037948541.HKD","LU2125154778.USD","LU1116320737.USD","LU0265550359.USD","SG9999015341.SGD","SG9999001440.SGD","BK4007","LU0106261372.USD","LU2461242641.AUD","SG9999002224.SGD","LU1941712348.USD","LU1983299246.USD","IE000M9KFDE8.USD","LU0203347892.USD","IE00BJJMRZ35.SGD","BK4550","LU0265550946.USD","LU2360032135.SGD","LU1571399168.USD","LU1093756168.USD","LU1585245621.USD","LU0203345920.USD","BK4533","LU1430594728.SGD","SG9999001176.USD","LU1093756325.SGD","LU2491050071.SGD","IE00BLSP4239.USD","LU2023250504.SGD","LU0130102774.USD","LU1066051225.USD","IE00BJT1NW94.SGD","LU1066053197.SGD","LU0980610538.SGD","LU1061106388.HKD","LU2468319806.SGD","LU1941712264.USD","LU0208291251.USD","BK4588","SG9999013999.USD","SG9999002232.USD","LU1069347547.HKD","LU1035773651.USD","SG9999001176.SGD","LU0130517989.USD","LU0942090050.USD","LU0477156953.USD","SG9999014575.USD","LU1989772840.SGD","LU1929549753.HKD","LU0098860793.USD","SGXZ57979304.SGD","LU1066051498.USD","LU1116320901.HKD","LU0266013472.USD","LU2125909593.SGD","LU2361044865.SGD","IE00BN8TJ469.HKD","IE00B2B36J28.USD","LU0965509101.SGD","LU0122379950.USD","LU1934455863.HKD","LU1917777945.USD","LU0432979614.USD","LU0965509010.AUD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0006306889.USD","LU1201861249.SGD","MRK","LU2361045086.USD","LU1934455194.USD","LU0320765489.SGD","LU1923622614.USD","LU1974910355.USD","LU2491049909.HKD","LU2089984988.USD","LU1162221912.USD","LU1989771016.USD","SG9999014559.SGD","LU0861579265.USD","LU2112291526.USD","SG9999014567.USD","LU2125154935.USD","SG9999014542.SGD","LU2324357040.USD","IE00BLSP4452.SGD","LU0868494708.USD","IE0002141913.USD","LU0965508806.USD","LU2361044949.HKD","LU1057294990.SGD","BK4585","BK4559","LU0234572021.USD","LU1934455277.USD","IE00B4R5TH58.HKD","LU0070302665.USD","LU2106854487.HKD","IE00B1BXHZ80.USD","LU1037948897.HKD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645890390","title":"默沙东(MRK)“K药”联合ADC疗法获欧盟批准 将用于膀胱癌成人患者治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2645890390","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645890390?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:23","pubTimestamp":1782300231,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美国医药巨头默沙东 宣布，欧洲联盟委员会已正式批准其重磅PD-1免疫疗法“K药”联合抗体偶联药物Padcev，用于不适合接受顺铂化疗的肌层浸润性膀胱癌成人患者的围手术期治疗。该方案涵盖了新辅助治疗(手术前)及随后的根治性膀胱切除术后辅助治疗(手术后)，也是欧盟目前批准的首个且唯一一个用于该患者群体的“PD-1抑制剂 + ADC”联合治疗方案。值得注意的是，该批准同时适用于K药的皮下注射剂型。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301854","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1291159041.SGD","LU0965509101.SGD","LU0861579265.USD","LU1929549753.HKD","LU2491050154.USD","BK4588","LU0868494617.USD","LU1037948541.HKD","LU1201861249.SGD","SG9999015341.SGD","SGXZ57979304.SGD","LU2361044865.SGD","LU0106261372.USD","LU1061106388.HKD","LU1023059063.AUD","LU0965508806.USD","LU2360032135.SGD","LU0203345920.USD","SG9999013999.USD","LU1989772840.SGD","LU0122379950.USD","LU2361045086.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","SG9999014542.SGD","LU2106854487.HKD","LU0058720904.USD","LU0868494708.USD","LU0320765646.SGD","LU1066051498.USD","SG9999001176.USD","LU0965509283.SGD","SG9999001440.SGD","BK4550","LU1989771016.USD","LU1917777945.USD","LU2491050071.SGD","LU1983299246.USD","LU2125909593.SGD","IE00B2B36J28.USD","LU0130102774.USD","LU0985320562.USD","LU2468319806.SGD","LU0265550359.USD","IE000M9KFDE8.USD","LU1934455277.USD","LU1093756325.SGD","LU0942090050.USD","LU0130517989.USD","LU1093756168.USD","LU1066051811.HKD","LU2361044949.HKD","LU2023250504.SGD","IE00B4R5TH58.HKD","BK4534","LU1934455194.USD","LU0203347892.USD","LU1699723380.USD","LU0289739699.SGD","IE00B1BXHZ80.USD","LU1585245621.USD","SG9999015358.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BLSP4452.SGD","LU2125154935.USD","LU2491049909.HKD","LU1037948897.HKD","LU2324357040.USD","LU1162221912.USD","LU1116320901.HKD","LU0208291251.USD","LU1035773651.USD","LU0320765489.SGD","LU1941712264.USD","LU2461242641.AUD","SG9999002224.SGD","LU0211331839.USD","LU0238689110.USD","LU0980610538.SGD","LU1923622614.USD","LU2023250843.SGD","SG9999002232.USD","LU0648001328.SGD","IE0009355771.USD","LU1430594728.SGD","LU0859254822.USD","LU2433249047.HKD","SG9999014575.USD","LU1934455863.HKD","LU1989772923.USD","LU0265550946.USD","BK4516","LU2089984988.USD","LU0006306889.USD","LU1116320737.USD","IE0002141913.USD","LU0965509010.AUD","LU0266013472.USD","LU0070302665.USD","LU0098860793.USD","MRK","SG9999001176.SGD","LU0477156953.USD","LU1941712348.USD","LU1974910355.USD","LU2125154778.USD","LU1066051225.USD","IE00BJT1NW94.SGD","BK4559","IE00BN8TJ469.HKD","LU0432979614.USD","LU2125909247.SGD","BK4533","LU1069347547.HKD","LU2357627491.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD","SG9999014567.USD","SG9999014559.SGD","BK4007","LU1066053197.SGD","LU1571399168.USD","LU0234572021.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171686564","title":"欧盟委员会批准Keytruda®（帕博利珠单抗）联合Padcev®（恩福妥单抗维多汀-ejfv）作为首个PD-1抑制剂联合抗体偶联药物治疗不适合顺铂的可切除非肌层浸润性膀胱癌成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1171686564","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171686564?lang=zh_cn&edition=full","pubTime":"2026-06-24 18:46","pubTimestamp":1782297966,"startTime":"0","endTime":"0","summary":"欧盟委员会已批准Keytruda®（帕博利珠单抗）联合Padcev®（恩福妥单抗维多汀-ejfv）方案，用于治疗不适合接受顺铂治疗、且肿瘤可切除的肌层浸润性膀胱癌成人患者。该方案是首个获批的PD-1抑制剂联合抗体偶联药物疗法，标志着此类患者治疗选择的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015341.SGD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU0122379950.USD","LU0058720904.USD","IE00B4R5TH58.HKD","BK4559","SG9999001440.SGD","LU2125909247.SGD","IE00BLSP4452.SGD","LU1989772840.SGD","LU0070302665.USD","LU0130517989.USD","IE00BBT3K403.USD","LU0477156953.USD","LU0265550946.USD","LU1934455863.HKD","LU1989771016.USD","LU2461242641.AUD","LU1066051498.USD","LU0432979614.USD","IE00BN8TJ469.HKD","LU0965509101.SGD","LU1093756325.SGD","LU1116320901.HKD","SG9999014567.USD","SGXZ57979304.SGD","LU1035773651.USD","LU0130102774.USD","IE00BSNM7G36.USD","LU0238689110.USD","SG9999001176.USD","LU0320765646.SGD","LU2361044949.HKD","LU0965509010.AUD","LU2125154778.USD","LU0098860793.USD","LU1934455277.USD","LU0868494708.USD","LU0861579265.USD","SG9999002224.SGD","LU2361044865.SGD","LU0106261372.USD","BK4588","LU1923622614.USD","LU2324357040.USD","LU1974910355.USD","SG9999002232.USD","LU2106854487.HKD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1571399168.USD","LU1983299246.USD","LU2023250843.SGD","BK4007","LU2112291526.USD","LU0965509283.SGD","LU1430594728.SGD","LU2491050071.SGD","LU1116320737.USD","LU0985320562.USD","LU2433249047.HKD","LU2125909593.SGD","SG9999014575.USD","LU2023250504.SGD","LU0266013472.USD","LU0208291251.USD","MRK","BK4550","LU0006306889.USD","LU0868494617.USD","LU1066053197.SGD","LU1585245621.USD","SG9999001176.SGD","LU0203345920.USD","BK4585","IE00B2B36J28.USD","LU1061106388.HKD","SG9999013999.USD","BK4533","LU1066051811.HKD","LU1934455194.USD","LU1066051225.USD","LU1201861249.SGD","LU0320765489.SGD","LU1989772923.USD","LU1037948541.HKD","LU1037948897.HKD","LU1291159041.SGD","LU0265550359.USD","LU2360032135.SGD","LU1929549753.HKD","IE0002141913.USD","LU1057294990.SGD","LU2491050154.USD","LU2491049909.HKD","LU2125154935.USD","LU0980610538.SGD","LU2357627491.SGD","LU0211331839.USD","LU0234572021.USD","LU1699723380.USD","IE0009355771.USD","LU1093756168.USD","LU2361045086.USD","BK4534","LU2468319806.SGD","IE00BJT1NW94.SGD","LU1941712348.USD","LU1162221912.USD","LU1023059063.AUD","SG9999014559.SGD","LU0648001328.SGD","LU1941712264.USD","LU0203347892.USD","LU2089984988.USD","SG9999014542.SGD","SG9999015358.SGD","LU0965508806.USD","BK4516","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU1917777945.USD","LU0942090050.USD","LU0859254822.USD","LU1069347547.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183162162","title":"异动解读｜默沙东盘中上涨3.03%，多重利好叠加催化股价走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1183162162","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183162162?lang=zh_cn&edition=full","pubTime":"2026-06-24 01:19","pubTimestamp":1782235152,"startTime":"0","endTime":"0","summary":"6月24日，默沙东盘中上涨3.03%，报118.98美元/股，成交额4.35亿美元。消息面上，多重利好叠加提振市场情绪。另一方面，据报道默沙东正洽谈以280亿至320亿美元收购癌症药物开发商Revolution Medicines，若达成将成为近年最大规模制药并购之一，有助于缓解Keytruda专利到期压力。此外，贝伦贝格将默沙东目标价从115美元上调至125美元，FactSet汇总分析师平均目标价为132.25美元，评级为\"增持\"。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645714888","title":"贝伦贝格上调默沙东目标价至125美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645714888","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645714888?lang=zh_cn&edition=full","pubTime":"2026-06-23 13:57","pubTimestamp":1782194221,"startTime":"0","endTime":"0","summary":"贝伦贝格将默沙东的目标价从115美元上调至125美元，维持“持有”评级。(格隆汇)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260623/32286915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0868494617.USD","IE00BN8TJ469.HKD","LU0477156953.USD","LU1989772923.USD","LU0965509101.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1941712264.USD","SG9999001176.USD","LU1116320901.HKD","LU1974910355.USD","LU2491050154.USD","LU1162221912.USD","SG9999014559.SGD","LU1983299246.USD","LU0130102774.USD","LU0130517989.USD","LU2125154935.USD","LU0965509010.AUD","IE0002141913.USD","LU2023250843.SGD","LU1066051811.HKD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0266013472.USD","LU1934455277.USD","BK4585","SG9999001440.SGD","LU1093756168.USD","LU0868494708.USD","LU0122379950.USD","BK4550","IE00BLSP4239.USD","LU0320765489.SGD","LU2112291526.USD","SG9999002224.SGD","LU0265550946.USD","BK4534","LU1571399168.USD","SG9999013999.USD","LU1201861249.SGD","LU1923622614.USD","LU0208291251.USD","LU0265550359.USD","MRK","SGXZ57979304.SGD","LU0203345920.USD","IE000M9KFDE8.USD","LU1066051225.USD","LU2433249047.HKD","BK4588","LU2360032135.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU1934455863.HKD","BK4007","LU2361045086.USD","LU2491050071.SGD","LU0070302665.USD","IE00B2B36J28.USD","LU1116320737.USD","IE00B1BXHZ80.USD","SG9999015341.SGD","LU0648001328.SGD","LU0006306889.USD","LU1066051498.USD","LU2361044865.SGD","LU1061106388.HKD","LU1929549753.HKD","LU1585245621.USD","LU1989772840.SGD","LU1989771016.USD","IE00BLSP4452.SGD","LU2125909247.SGD","LU0238689110.USD","LU1941712348.USD","SG9999014575.USD","LU1934455194.USD","SG9999002232.USD","BK4516","LU0098860793.USD","LU0980610538.SGD","LU2461242641.AUD","LU2106854487.HKD","LU0859254822.USD","LU1291159041.SGD","LU2125154778.USD","IE00BBT3K403.USD","LU1069347547.HKD","SG9999001176.SGD","LU1430594728.SGD","SG9999014567.USD","LU1023059063.AUD","LU0942090050.USD","LU0211331839.USD","LU0289739699.SGD","LU0320765646.SGD","BK4533","LU0203347892.USD","BK4559","LU1037948897.HKD","LU0965508806.USD","LU1917777945.USD","LU2023250504.SGD","LU0106261372.USD","IE0009355771.USD","LU2361044949.HKD","LU1093756325.SGD","LU0861579265.USD","LU1035773651.USD","LU1699723380.USD","LU2125909593.SGD","SG9999015358.SGD","LU2089984988.USD","LU0432979614.USD","LU2357627491.SGD","LU2491049909.HKD","LU0965509283.SGD","LU0234572021.USD","IE00BJJMRZ35.SGD","LU0985320562.USD","SG9999014542.SGD","LU1066053197.SGD","LU1037948541.HKD","IE00BSNM7G36.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133249116","title":"默沙东Tulisokibart在3期Atlas-Uc诱导研究中达成主要及关键次要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1133249116","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133249116?lang=zh_cn&edition=full","pubTime":"2026-06-22 18:47","pubTimestamp":1782125261,"startTime":"0","endTime":"0","summary":"默沙东公司宣布，其药物Tulisokibart在针对中重度活动性溃疡性结肠炎患者的3期Atlas-Uc诱导研究中，成功达到了主要终点及所有关键次要终点。\n该研究结果展示了Tulisokibart在诱导治疗期的有效性与潜力，为这一患者群体带来了新的治疗希望。研究数据的详细分析正在进行中，默沙东计划在未来的医学会议上公布完整结果，并与全球卫生监管机构展开沟通。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014542.SGD","LU2112291526.USD","IE00BBT3K403.USD","LU0130102774.USD","IE000M9KFDE8.USD","LU1116320901.HKD","LU1983299246.USD","BK4534","LU1934455194.USD","LU2468319806.SGD","SG9999014559.SGD","IE00B4R5TH58.HKD","LU0208291251.USD","SG9999002224.SGD","LU1934455277.USD","LU0265550359.USD","LU1061106388.HKD","IE0002141913.USD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1989772923.USD","LU2125154778.USD","SG9999001176.USD","LU1035773651.USD","LU0106261372.USD","LU0265550946.USD","LU2089984988.USD","MRK","LU0965508806.USD","LU1571399168.USD","LU2125909593.SGD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU2361045086.USD","LU0122379950.USD","IE00BN8TJ469.HKD","LU0965509283.SGD","LU2125909247.SGD","LU0861579265.USD","LU0098860793.USD","LU2361044865.SGD","LU0980610538.SGD","LU0203345920.USD","LU1066051498.USD","SG9999013999.USD","SG9999014567.USD","LU1023059063.AUD","LU2433249047.HKD","LU2491050154.USD","LU0648001328.SGD","LU1941712264.USD","LU1989772840.SGD","IE00BLSP4239.USD","LU1093756168.USD","LU1201861249.SGD","LU0859254822.USD","SG9999015341.SGD","LU1585245621.USD","LU1057294990.SGD","LU0965509010.AUD","LU1037948541.HKD","LU2491050071.SGD","LU2491049909.HKD","LU2461242641.AUD","LU1291159041.SGD","LU2357627491.SGD","LU0477156953.USD","LU1699723380.USD","LU0432979614.USD","LU0965509101.SGD","SG9999014575.USD","LU2360032135.SGD","LU0868494708.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU0130517989.USD","BK4007","IE00BFTCPJ56.SGD","LU0320765646.SGD","LU0266013472.USD","LU2023250504.SGD","LU1116320737.USD","LU1923622614.USD","LU1934455863.HKD","BK4559","LU1917777945.USD","LU1929549753.HKD","BK4588","BK4516","LU1037948897.HKD","IE0009355771.USD","LU2106854487.HKD","LU1066053197.SGD","IE00B1BXHZ80.USD","LU0006306889.USD","LU2125154935.USD","LU0211331839.USD","LU0985320562.USD","BK4533","LU2023250843.SGD","SG9999002232.USD","LU0238689110.USD","BK4585","IE00BJT1NW94.SGD","LU1066051225.USD","SG9999015358.SGD","LU0058720904.USD","LU0320765489.SGD","LU1162221912.USD","SGXZ57979304.SGD","SG9999001440.SGD","LU1974910355.USD","BK4550","LU1069347547.HKD","LU1989771016.USD","IE00B2B36J28.USD","LU0868494617.USD","LU0070302665.USD","LU0203347892.USD","LU1941712348.USD","LU2361044949.HKD","SG9999001176.SGD","LU0942090050.USD","LU0289739699.SGD","LU1430594728.SGD","LU1066051811.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644082152","title":"默沙东(MRK)肺炎球菌疫苗新增儿童适用人群 获批复盖2至17岁高危青少年","url":"https://stock-news.laohu8.com/highlight/detail?id=2644082152","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644082152?lang=zh_cn&edition=full","pubTime":"2026-06-18 23:06","pubTimestamp":1781795161,"startTime":"0","endTime":"0","summary":"本次获批后，该单剂疫苗可用于 2 至 17 岁人群，适用人群需完成肺炎球菌基础疫苗接种，且伴随至少一类慢性基础病，属于肺炎球菌感染高风险群体。在此之前，该疫苗仅获批面向 18 周岁及以上成年人，用于预防侵袭性肺炎球菌感染与肺炎病症，本次儿童适应症落地进一步拓宽产品临床使用场景。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301702","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361045086.USD","LU1066053197.SGD","LU1923622614.USD","LU1989771016.USD","SG9999002232.USD","SG9999014575.USD","IE00B1BXHZ80.USD","LU0477156953.USD","LU1934455863.HKD","LU2360032135.SGD","LU1989772840.SGD","LU0211331839.USD","IE000M9KFDE8.USD","LU0266013472.USD","IE00B2B36J28.USD","LU0432979614.USD","LU1061106388.HKD","LU2125154778.USD","LU2324357040.USD","LU0130102774.USD","LU0122379950.USD","LU0980610538.SGD","SG9999014559.SGD","LU0058720904.USD","BK4007","LU0203345920.USD","LU1162221912.USD","LU1941712348.USD","LU0203347892.USD","LU2125909593.SGD","LU0320765646.SGD","LU1989772923.USD","LU1069347547.HKD","LU0868494708.USD","LU1057294990.SGD","IE00BLSP4452.SGD","LU0965509283.SGD","LU2089984988.USD","SG9999013999.USD","LU2361044949.HKD","LU2468319806.SGD","SG9999001176.SGD","IE00BN8TJ469.HKD","LU1023059063.AUD","LU0130517989.USD","LU2112291526.USD","LU1430594728.SGD","LU2125154935.USD","SG9999014567.USD","BK4533","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2491049909.HKD","BK4534","SGXZ57979304.SGD","LU1201861249.SGD","LU2461242641.AUD","LU2023250504.SGD","LU1917777945.USD","LU1974910355.USD","IE00BBT3K403.USD","LU0861579265.USD","LU1699723380.USD","LU1941712264.USD","LU0859254822.USD","LU1983299246.USD","LU2125909247.SGD","LU0985320562.USD","LU1116320901.HKD","LU0234572021.USD","SG9999014542.SGD","LU0868494617.USD","LU1037948897.HKD","LU1571399168.USD","BK4550","LU0942090050.USD","LU1929549753.HKD","SG9999001176.USD","LU2023250843.SGD","BK4516","IE00BSNM7G36.USD","MRK","SG9999001440.SGD","LU2361044865.SGD","LU0208291251.USD","LU1037948541.HKD","LU1093756168.USD","SG9999015358.SGD","LU0238689110.USD","BK4585","LU1116320737.USD","LU0106261372.USD","LU0965509010.AUD","LU1066051225.USD","IE00BLSP4239.USD","LU2491050071.SGD","LU0265550359.USD","LU2357627491.SGD","LU0320765489.SGD","LU1934455277.USD","LU1093756325.SGD","SG9999002224.SGD","BK4559","LU0965509101.SGD","IE00BFTCPJ56.SGD","LU1066051498.USD","LU0965508806.USD","LU1934455194.USD","LU0006306889.USD","LU2491050154.USD","IE00BJJMRZ35.SGD","LU2433249047.HKD","LU1585245621.USD","LU0648001328.SGD","LU0098860793.USD","LU1291159041.SGD","LU1035773651.USD","LU0265550946.USD","LU0070302665.USD","LU1066051811.HKD","BK4588","LU2106854487.HKD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","SG9999015341.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170554143","title":"异动解读｜默沙东盘中下跌3.01%，报111.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170554143","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170554143?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:53","pubTimestamp":1781794391,"startTime":"0","endTime":"0","summary":"6月18日，默沙东盘中下跌3.01%，报111.97美元/股，成交额5.36亿美元。默沙东所在的制药行业中，个股普遍承压，其中礼来跌1.74%，强生跌2.54%，辉瑞跌3.7%，施贵宝跌2.97%，Zoetis Inc.涨0.96%。默克制药公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品，营运主要包括制药及动物保健国际两个经营分部。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195877790","title":"默沙东：在中国获批用于婴幼儿下呼吸道感染治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1195877790","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195877790?lang=zh_cn&edition=full","pubTime":"2026-06-15 15:38","pubTimestamp":1781509132,"startTime":"0","endTime":"0","summary":"默沙东公司宣布，其用于治疗婴幼儿下呼吸道感染的药物已在中国获得监管批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0265550946.USD","LU0985320562.USD","BK4559","LU1057294990.SGD","LU2361045086.USD","LU2357627491.SGD","LU0861579265.USD","LU2125154935.USD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","LU0265550359.USD","LU1917777945.USD","IE00BLSP4239.USD","LU1989772923.USD","LU1699723380.USD","LU0942090050.USD","LU2361044865.SGD","LU2461242641.AUD","LU1430594728.SGD","LU0070302665.USD","LU1934455863.HKD","LU1941712264.USD","SG9999002224.SGD","LU0208291251.USD","LU0130517989.USD","MRK","LU0965508806.USD","LU1934455277.USD","BK4007","LU2125909593.SGD","LU1989771016.USD","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0965509283.SGD","LU1035773651.USD","LU1974910355.USD","SG9999014567.USD","LU0098860793.USD","LU1023059063.AUD","IE00BN8TJ469.HKD","LU2023250504.SGD","SG9999015341.SGD","LU1116320901.HKD","LU1989772840.SGD","BK4588","IE00B2B36J28.USD","LU2112291526.USD","LU0859254822.USD","LU0266013472.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0980610538.SGD","IE0009355771.USD","LU0432979614.USD","LU0868494617.USD","LU0965509101.SGD","LU0965509010.AUD","LU0058720904.USD","LU1066051225.USD","BK4550","LU1923622614.USD","LU1929549753.HKD","LU2468319806.SGD","IE00BSNM7G36.USD","LU0238689110.USD","LU1037948897.HKD","IE00B4R5TH58.HKD","LU0106261372.USD","SG9999013999.USD","LU2491050154.USD","LU2125909247.SGD","LU1037948541.HKD","LU1061106388.HKD","LU0868494708.USD","LU2491050071.SGD","SG9999014575.USD","SG9999014542.SGD","LU0234572021.USD","LU0477156953.USD","LU2106854487.HKD","LU1066051811.HKD","LU1116320737.USD","LU2491049909.HKD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","LU0320765646.SGD","LU2023250843.SGD","SG9999015358.SGD","LU1066053197.SGD","LU1585245621.USD","SG9999001440.SGD","SG9999002232.USD","LU1983299246.USD","LU0648001328.SGD","LU0320765489.SGD","LU1066051498.USD","LU1093756325.SGD","SG9999001176.USD","LU0203347892.USD","LU1093756168.USD","LU1941712348.USD","BK4516","BK4534","LU2433249047.HKD","LU1291159041.SGD","LU1934455194.USD","LU0130102774.USD","LU2360032135.SGD","LU1201861249.SGD","LU1162221912.USD","IE0002141913.USD","LU2361044949.HKD","LU2089984988.USD","BK4533","LU2125154778.USD","SG9999014559.SGD","LU1571399168.USD","LU0122379950.USD","LU2324357040.USD","LU0006306889.USD","LU1069347547.HKD","LU0203345920.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289826","title":"默沙东(MRK)旗下默克动物保健收购动物农业科技创新企业TARGAN","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289826","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642289826?lang=zh_cn&edition=full","pubTime":"2026-06-11 19:03","pubTimestamp":1781175805,"startTime":"0","endTime":"0","summary":"作为TARGAN自2017年以来的核心投资者及最大股东之一，默克动物保健表示，此举旨在加速其在全球家禽生物制药及智能化设备领域的战略布局。行业分析人士认为， 默克动物保健此次从“战略股东”身份向前一步完成全资收购，不仅获得了TARGAN先进的研发能力，更实现了“动保疫苗”与“智能接种/分拣设备”的深度产业闭环。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301433","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU2491049909.HKD","LU1066053197.SGD","LU1066051498.USD","SG9999015358.SGD","LU2491050071.SGD","LU0320765489.SGD","LU1983299246.USD","LU0965509283.SGD","LU0234572021.USD","LU0432979614.USD","IE00BLSP4452.SGD","LU1093756168.USD","LU2023250504.SGD","LU1989772840.SGD","BK4007","SG9999002224.SGD","LU0320765646.SGD","LU1069347547.HKD","LU1571399168.USD","LU1093756325.SGD","BK4533","BK4516","LU0965509010.AUD","LU2125154778.USD","LU1699723380.USD","LU2023250843.SGD","LU0477156953.USD","LU2360032135.SGD","LU2461242641.AUD","LU0208291251.USD","LU0868494617.USD","SG9999002232.USD","LU1162221912.USD","LU0211331839.USD","LU0130102774.USD","LU1066051225.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU0265550359.USD","LU2125154935.USD","LU2468319806.SGD","LU0098860793.USD","LU1989771016.USD","LU0980610538.SGD","SG9999001440.SGD","IE00BLSP4239.USD","LU1934455863.HKD","LU0203347892.USD","LU1917777945.USD","BK4588","IE00BJJMRZ35.SGD","LU1037948897.HKD","SG9999015341.SGD","LU0006306889.USD","LU1035773651.USD","IE0009355771.USD","LU0289739699.SGD","BK4534","MRK","IE00BSNM7G36.USD","SG9999001176.USD","LU1585245621.USD","LU0942090050.USD","LU0058720904.USD","IE000M9KFDE8.USD","LU0106261372.USD","SG9999014575.USD","LU0868494708.USD","LU2433249047.HKD","LU2112291526.USD","LU0122379950.USD","LU0965509101.SGD","LU1116320901.HKD","LU2361044865.SGD","LU0266013472.USD","LU0265550946.USD","BK4550","LU2357627491.SGD","LU0238689110.USD","SG9999014559.SGD","LU0859254822.USD","LU2106854487.HKD","LU1934455277.USD","LU2125909593.SGD","LU1201861249.SGD","BK4559","LU1974910355.USD","LU0965508806.USD","IE00B2B36J28.USD","LU0861579265.USD","SG9999014542.SGD","LU1941712264.USD","LU1037948541.HKD","IE00BN8TJ469.HKD","LU1941712348.USD","LU1291159041.SGD","LU0648001328.SGD","LU2361044949.HKD","LU0130517989.USD","LU2324357040.USD","IE00BBT3K403.USD","LU1116320737.USD","LU1923622614.USD","LU0985320562.USD","LU2491050154.USD","LU2125909247.SGD","LU1023059063.AUD","LU1989772923.USD","SG9999013999.USD","SG9999001176.SGD","SG9999014567.USD","LU1929549753.HKD","BK4585","SGXZ57979304.SGD","LU2089984988.USD","LU1066051811.HKD","IE0002141913.USD","LU1934455194.USD","IE00B1BXHZ80.USD","LU2361045086.USD","LU0203345920.USD","IE00B4R5TH58.HKD","LU0070302665.USD","LU1057294990.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103572899","title":"默沙东高管表示：我们关注更广泛的肥胖领域，但更聚焦于其并发症而非单纯肥胖","url":"https://stock-news.laohu8.com/highlight/detail?id=1103572899","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103572899?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:49","pubTimestamp":1781020196,"startTime":"0","endTime":"0","summary":"默沙东的一位高管近日指出，公司对更广泛的肥胖领域抱有浓厚兴趣，但其关注重点并非肥胖本身，而是与之相关的各类并发症。这番表态揭示了该公司在相关治疗领域可能采取的战略方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","SG9999002232.USD","LU1093756325.SGD","LU0965509010.AUD","LU1989771016.USD","LU0985320562.USD","LU0965509283.SGD","LU1941712264.USD","LU1917777945.USD","MRK","SG9999014575.USD","LU2023250843.SGD","BK4516","LU0432979614.USD","LU0265550359.USD","LU0106261372.USD","SG9999014567.USD","LU1934455863.HKD","LU0203345920.USD","LU0859254822.USD","BK4559","IE000M9KFDE8.USD","LU1162221912.USD","LU0122379950.USD","LU0868494617.USD","LU0320765489.SGD","LU1929549753.HKD","BK4534","LU2491050154.USD","LU0070302665.USD","LU2433249047.HKD","SG9999001440.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU2089984988.USD","LU2461242641.AUD","SG9999001176.SGD","LU2491049909.HKD","LU2324357040.USD","LU1989772923.USD","BK4533","LU2023250504.SGD","LU2125154778.USD","LU0006306889.USD","LU1201861249.SGD","LU1941712348.USD","LU1037948541.HKD","LU1983299246.USD","LU0203347892.USD","LU1430594728.SGD","LU0965509101.SGD","LU2125154935.USD","LU0942090050.USD","LU1585245621.USD","LU1934455194.USD","IE0009355771.USD","SG9999014559.SGD","LU1023059063.AUD","BK4007","SG9999001176.USD","IE00BLSP4452.SGD","LU0130102774.USD","LU1934455277.USD","SGXZ57979304.SGD","LU2360032135.SGD","IE0002141913.USD","LU1923622614.USD","LU1066053197.SGD","SG9999013999.USD","IE00BBT3K403.USD","LU2361044865.SGD","IE00B4R5TH58.HKD","SG9999015341.SGD","LU1066051225.USD","LU0234572021.USD","LU1699723380.USD","BK4550","LU0320765646.SGD","SLIM","LU0861579265.USD","LU1291159041.SGD","LU0289739699.SGD","LU0211331839.USD","LU0238689110.USD","LU1116320737.USD","IE00BSNM7G36.USD","LU0058720904.USD","LU1066051498.USD","LU1057294990.SGD","LU1093756168.USD","LU1989772840.SGD","LU2468319806.SGD","IE00B1BXHZ80.USD","LU0648001328.SGD","LU0868494708.USD","SG9999015358.SGD","LU2125909593.SGD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU0098860793.USD","LU2106854487.HKD","LU1974910355.USD","LU0265550946.USD","LU1037948897.HKD","LU1061106388.HKD","LU1116320901.HKD","BK4588","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU0477156953.USD","LU2125909247.SGD","BK4585","LU1069347547.HKD","LU0266013472.USD","LU1035773651.USD","LU0130517989.USD","LU2112291526.USD","SG9999014542.SGD","IE00BLSP4239.USD","LU0965508806.USD","LU2357627491.SGD","LU0208291251.USD","LU0980610538.SGD","LU2361045086.USD","LU2491050071.SGD","LU2361044949.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190170745","title":"默沙东高管表示：“国家授予恩利西肽的优先审评券正稳步推进”","url":"https://stock-news.laohu8.com/highlight/detail?id=1190170745","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190170745?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:49","pubTimestamp":1781020146,"startTime":"0","endTime":"0","summary":"默沙东的一位高管近日表示，公司有充分迹象表明，为旗下药物恩利西肽（Enlicitide）所获颁的国家优先审评凭证，其相关进程正在积极向前推进。这一表态传递出该关键监管激励措施进展顺利的明确信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","IE00BLSP4452.SGD","LU2361044949.HKD","LU0106261372.USD","LU0122379950.USD","LU0265550359.USD","LU2324357040.USD","LU0868494708.USD","LU1037948541.HKD","LU2491049909.HKD","LU0965508806.USD","LU0130102774.USD","LU0208291251.USD","LU1941712348.USD","LU0320765489.SGD","SG9999001440.SGD","LU1066051225.USD","SG9999014575.USD","IE00BSNM7G36.USD","LU2357627491.SGD","SG9999014559.SGD","LU1934455277.USD","LU1066051498.USD","BK4588","LU2023250843.SGD","LU1069347547.HKD","LU0477156953.USD","SG9999014542.SGD","LU1066053197.SGD","LU1989772840.SGD","LU1571399168.USD","LU2361044865.SGD","LU0234572021.USD","BK4533","IE00B2B36J28.USD","SG9999015341.SGD","LU0965509010.AUD","IE00BLSP4239.USD","LU0985320562.USD","LU2361045086.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU1430594728.SGD","LU2360032135.SGD","LU2089984988.USD","LU1116320737.USD","LU2125154935.USD","BK4559","LU2433249047.HKD","LU1974910355.USD","LU1923622614.USD","LU2461242641.AUD","LU2125909593.SGD","LU1983299246.USD","LU1093756325.SGD","LU0203345920.USD","BK4585","LU1057294990.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0859254822.USD","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","IE00B1BXHZ80.USD","MRK","LU2468319806.SGD","LU0006306889.USD","LU1989771016.USD","LU1917777945.USD","BK4516","BK4534","IE00BBT3K403.USD","SG9999015358.SGD","LU0070302665.USD","IE0002141913.USD","LU1035773651.USD","SG9999014567.USD","IE0009355771.USD","SG9999002232.USD","LU0058720904.USD","LU2125154778.USD","LU0965509101.SGD","LU0289739699.SGD","LU0432979614.USD","LU0965509283.SGD","LU0266013472.USD","LU0098860793.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0980610538.SGD","LU0203347892.USD","SG9999002224.SGD","LU0238689110.USD","LU2106854487.HKD","LU1934455194.USD","LU2125909247.SGD","LU1989772923.USD","LU0868494617.USD","SG9999013999.USD","BK4550","LU1066051811.HKD","LU0265550946.USD","LU1201861249.SGD","LU1941712264.USD","LU2023250504.SGD","LU2491050154.USD","LU2112291526.USD","LU1699723380.USD","LU1116320901.HKD","SG9999001176.SGD","LU0942090050.USD","LU1093756168.USD","LU1585245621.USD","BK4007","LU1061106388.HKD","LU0130517989.USD","LU0648001328.SGD","LU1037948897.HKD","LU1929549753.HKD","LU1934455863.HKD","LU0211331839.USD","LU0861579265.USD","LU2491050071.SGD","LU1291159041.SGD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104876485","title":"默沙东CEO于高盛医疗健康大会表示：公司将聚焦10亿至150亿美元并购“甜蜜点”","url":"https://stock-news.laohu8.com/highlight/detail?id=1104876485","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104876485?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:36","pubTimestamp":1781019409,"startTime":"0","endTime":"0","summary":"在高盛医疗健康大会上，默沙东首席执行官阐述了公司的未来并购战略，明确指出将把重点放在交易规模在10亿至150亿美元之间的“甜蜜点”上。这一战略定位旨在通过精准且规模适中的收购，有效补充和强化公司的产品管线，同时平衡风险与增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","IE000M9KFDE8.USD","LU0208291251.USD","LU0980610538.SGD","LU0265550359.USD","LU2125909593.SGD","LU1585245621.USD","SG9999001440.SGD","LU1057294990.SGD","LU1066051811.HKD","SG9999014542.SGD","LU0868494617.USD","SG9999013999.USD","BK4516","SG9999015358.SGD","LU0266013472.USD","SG9999014575.USD","LU0648001328.SGD","LU1989772923.USD","LU0965509101.SGD","IE00B2B36J28.USD","BK4550","LU0265550946.USD","LU0432979614.USD","LU0861579265.USD","LU1093756325.SGD","LU1699723380.USD","LU2491050071.SGD","LU1066051225.USD","LU1923622614.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU0106261372.USD","BK4559","LU1983299246.USD","LU0965509010.AUD","LU0006306889.USD","LU2468319806.SGD","LU0965508806.USD","LU2023250843.SGD","LU1066051498.USD","LU0477156953.USD","LU1941712348.USD","LU2433249047.HKD","IE00BN8TJ469.HKD","BK4585","LU1035773651.USD","LU1066053197.SGD","LU1917777945.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","SG9999015341.SGD","LU2360032135.SGD","IE00BLSP4239.USD","LU2106854487.HKD","BK4533","BK4588","LU1989772840.SGD","LU2023250504.SGD","LU2112291526.USD","LU0122379950.USD","LU1037948541.HKD","LU1093756168.USD","LU0098860793.USD","LU1061106388.HKD","LU0289739699.SGD","LU0130517989.USD","LU1116320737.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU1974910355.USD","LU1989771016.USD","LU0985320562.USD","SG9999014567.USD","LU0859254822.USD","IE00BBT3K403.USD","SG9999002232.USD","LU0058720904.USD","LU1934455863.HKD","BK4534","LU1934455194.USD","LU0130102774.USD","LU2125909247.SGD","LU1023059063.AUD","LU0238689110.USD","IE00B1BXHZ80.USD","LU2361044865.SGD","SG9999014559.SGD","LU1929549753.HKD","IE0009355771.USD","LU1934455277.USD","LU2357627491.SGD","LU1291159041.SGD","LU0234572021.USD","LU0320765646.SGD","LU1571399168.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","LU1069347547.HKD","LU2324357040.USD","LU2361044949.HKD","LU2361045086.USD","BK4007","MRK","LU0203345920.USD","LU2461242641.AUD","LU0942090050.USD","LU2125154935.USD","LU0070302665.USD","LU1116320901.HKD","IE0002141913.USD","LU0965509283.SGD","LU2491049909.HKD","LU0868494708.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU2125154778.USD","SG9999001176.USD","LU1037948897.HKD","LU1201861249.SGD","LU1430594728.SGD","LU2491050154.USD","LU0211331839.USD","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642545787","title":"默沙东(MRK.US)与吉利德科学(GILD.US)联合HIV药物三期临床试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2642545787","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642545787?lang=zh_cn&edition=full","pubTime":"2026-06-09 14:47","pubTimestamp":1780987633,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，默沙东和吉利德科学表示，含有默沙东药物伊斯拉曲韦和吉利德药物莱那卡帕韦的复方药片的两项 3 期试验的初步结果达到了主要终点。此外，研究发现 islatravir/lenacapavir不劣于必妥维和标准口服抗逆转录病毒疗法。此外，两家公司宣布，根据数据监测委员会的建议，他们将终止吉利德的 Trodelvy 与默沙东的Keytruda一线治疗转移性非小细胞肺癌的 3 期 KEYNOTE-D46/EVOKE-03 研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0009355771.USD","LU0648001328.SGD","IE00BBT3K403.USD","LU0942090050.USD","LU2125909593.SGD","SG9999001440.SGD","LU0106261372.USD","IE00BLSP4239.USD","LU0320765992.SGD","LU1934455277.USD","LU2361044865.SGD","BK4583","LU2125154778.USD","LU0130517989.USD","IE0002141913.USD","BK4534","LU2112291526.USD","BK4588","LU0432979614.USD","LU2023250843.SGD","LU0868494708.USD","LU1778281490.HKD","LU1934455863.HKD","LU1917777945.USD","IE00B7SZLL34.SGD","IE00BLSP4452.SGD","LU1571399168.USD","LU0058720904.USD","LU1674673428.USD","IE00B4R5TH58.HKD","LU2461242641.AUD","LU1699723380.USD","IE00B2B36J28.USD","SG9999015341.SGD","LU0203347892.USD","LU0211331839.USD","LU0265550359.USD","GILD","LU0266013472.USD","LU1061106388.HKD","LU0965509283.SGD","SG9999014567.USD","LU2491050154.USD","LU1929549753.HKD","BK4532","LU1291159041.SGD","LU1674673691.USD","LU1093756325.SGD","IE0002270589.USD","BK4007","IE00B1BXHZ80.USD","IE00B19Z3581.USD","LU2360032135.SGD","LU0208291251.USD","LU0965508806.USD","LU1941712264.USD","LU1066051225.USD","LU2433249047.HKD","LU0130102774.USD","LU1116320737.USD","SG9999015945.SGD","LU1989771016.USD","SG9999001176.USD","LU0070302665.USD","SG9999015358.SGD","SG9999014542.SGD","LU1941712348.USD","LU0234570918.USD","LU1934455194.USD","SG9999002224.SGD","LU0868494617.USD","IE000M9KFDE8.USD","LU0098860793.USD","MRK","LU1066051498.USD","LU0238689110.USD","LU0289739699.SGD","LU1923622614.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","SG9999015952.SGD","LU1430594728.SGD","LU1069347547.HKD","LU1023059063.AUD","LU0965509010.AUD","LU2324357040.USD","BK4550","LU0006306889.USD","LU1066051811.HKD","LU1983299246.USD","LU0965509101.SGD","LU0823416689.USD","LU0980610538.SGD","BK4559","LU0234572021.USD","SG9999013999.USD","LU1066053197.SGD","LU0114720955.EUR","BK4578","LU0122379950.USD","SG9999002232.USD","LU0861579265.USD","LU2491049909.HKD","LU1162221912.USD","SG9999014575.USD","SG9999015978.USD","BK4139","LU2125154935.USD","IE00BZ1G4Q59.USD","BK4566","SG9999015986.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","LU0109394709.USD","LU2106854487.HKD","LU2357627491.SGD","LU2125909247.SGD","LU0859254822.USD","LU1989772923.USD","LU1839511570.USD","LU1989772840.SGD","IE00BN8TJ469.HKD","LU1057294990.SGD","LU1201861249.SGD","LU1585245621.USD","LU0203345920.USD","LU1037948897.HKD","LU1035773651.USD","BK4516","LU2491050071.SGD","LU0320765646.SGD","IE00B3T34201.USD","LU1093756168.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU1116320901.HKD","LU2361044949.HKD","LU0985320562.USD","SGXZ57979304.SGD","BK4533","IE00BJT1NW94.SGD","LU2023250504.SGD","SG9999001176.SGD","LU1974910355.USD","BK4585","LU0265550946.USD","LU0882574055.USD","LU1037948541.HKD","LU2087621335.USD","BK4568","LU2468319806.SGD","LU0477156953.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","SG9999014559.SGD","LU2361045086.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181239601","title":"吉利德科学：Islatravir/Lenacapavir HIV治疗方案在两项试验中均达到第48周主要疗效终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1181239601","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181239601?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:37","pubTimestamp":1780951065,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，其基于islatravir与lenacapavir的HIV联合治疗方案，在两项关键临床试验中，均成功达到了预设的第48周主要疗效终点。这一积极结果标志着该创新疗法在抑制病毒载量方面展现出显著效果，为HIV感染者提供了潜在的全新长效治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU0203347892.USD","LU1430594728.SGD","SG9999015952.SGD","MRK","LU2125909593.SGD","LU1066051498.USD","LU1116320737.USD","LU1839511570.USD","LU1585245621.USD","LU1291159041.SGD","LU0114720955.EUR","LU0109394709.USD","LU0203345920.USD","SG9999002224.SGD","BK4588","LU2324357040.USD","SG9999015978.USD","SGXZ57979304.SGD","GILD","IE00BBT3K403.USD","LU0320765489.SGD","LU0058720904.USD","IE000M9KFDE8.USD","LU0130517989.USD","BK4578","LU1037948541.HKD","LU2023250843.SGD","IE00BJT1NW94.SGD","IE00BKVL7J92.USD","LU2361044865.SGD","IE00B4R5TH58.HKD","LU0965509010.AUD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU2491049909.HKD","SG9999014559.SGD","LU0965509283.SGD","BK4139","IE00B1BXHZ80.USD","LU2125154935.USD","SG9999015341.SGD","LU1674673428.USD","IE00BZ1G4Q59.USD","LU2461242641.AUD","LU1093756168.USD","LU1674673691.USD","LU0859254822.USD","LU1571399168.USD","LU2361045086.USD","BK4007","LU0432979614.USD","LU0208291251.USD","LU1917777945.USD","SG9999001176.USD","IE00BFTCPJ56.SGD","LU2087621335.USD","SG9999015358.SGD","LU1116320901.HKD","SG9999014575.USD","LU1941712348.USD","BK4585","LU2491050071.SGD","IE00BSNM7G36.USD","SG9999013999.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU0098860793.USD","LU1066051225.USD","LU2125154778.USD","IE00BN8TJ469.HKD","LU1989772840.SGD","LU2468319806.SGD","LU1934455863.HKD","LU0861579265.USD","LU0965508806.USD","LU1061106388.HKD","SG9999014542.SGD","IE00B7SZLL34.SGD","LU0130102774.USD","LU0234570918.USD","BK4550","LU0265550359.USD","LU0234572021.USD","BK4566","IE00BLSP4239.USD","LU2491050154.USD","LU0266013472.USD","BK4534","LU1069347547.HKD","SG9999015945.SGD","LU0477156953.USD","BK4532","LU1035773651.USD","SG9999002232.USD","LU1989771016.USD","LU1934455194.USD","LU2125909247.SGD","BK4583","LU1162221912.USD","SG9999015986.USD","LU1201861249.SGD","IE00B19Z3581.USD","LU1934455277.USD","LU0985320562.USD","LU0965509101.SGD","IE0002141913.USD","LU0868494617.USD","LU1941712264.USD","LU2089984988.USD","BK4568","LU0211331839.USD","LU0265550946.USD","LU1037948897.HKD","LU1023059063.AUD","BK4559","LU0320765992.SGD","LU0289739699.SGD","SG9999014567.USD","LU0868494708.USD","LU1778281490.HKD","LU1699723380.USD","IE00B3T34201.USD","BK4533","LU2361044949.HKD","LU0238689110.USD","LU0823416689.USD","LU1066051811.HKD","IE0002270589.USD","LU1989772923.USD","LU0882574055.USD","SG9999001440.SGD","LU2357627491.SGD","LU2112291526.USD","LU0320765646.SGD","LU0648001328.SGD","LU0070302665.USD","LU0889565916.HKD","LU0106261372.USD","LU0980610538.SGD","LU1974910355.USD","LU2023250504.SGD","IE0009355771.USD","LU1923622614.USD","IE00BLSP4452.SGD","LU0006306889.USD","LU0942090050.USD","LU1093756325.SGD","LU2433249047.HKD","LU1057294990.SGD","LU1066053197.SGD","IE00B2B36J28.USD","LU2106854487.HKD","BK4516","LU1929549753.HKD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164602486","title":"吉利德科学：Trodelvy与Keytruda联用的安全性特征与各药物已知安全性一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1164602486","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164602486?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:32","pubTimestamp":1780950760,"startTime":"0","endTime":"0","summary":"吉利德科学公司公布的数据显示，其抗体偶联药物Trodelvy与默沙东公司的Keytruda联合使用的安全性特征，与两种药物各自已知的安全性情况保持一致。这一发现为评估该联合疗法的潜力提供了重要的安全性基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU0208291251.USD","LU0980610538.SGD","LU0265550359.USD","LU2125909593.SGD","LU1585245621.USD","BK4578","SG9999001440.SGD","LU1057294990.SGD","LU1066051811.HKD","SG9999014542.SGD","LU0320765992.SGD","LU0868494617.USD","SG9999013999.USD","BK4139","BK4516","SG9999015358.SGD","LU0266013472.USD","SG9999014575.USD","LU0648001328.SGD","BK4532","LU1989772923.USD","LU0965509101.SGD","IE00B2B36J28.USD","BK4550","LU0265550946.USD","LU0432979614.USD","LU0861579265.USD","LU1093756325.SGD","LU1699723380.USD","LU2491050071.SGD","LU1066051225.USD","LU1923622614.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU0106261372.USD","BK4559","LU1983299246.USD","LU0965509010.AUD","LU0006306889.USD","LU2468319806.SGD","SG9999015986.USD","LU0965508806.USD","LU2023250843.SGD","LU1066051498.USD","IE00B3T34201.USD","LU0477156953.USD","LU1941712348.USD","LU2433249047.HKD","IE00BN8TJ469.HKD","BK4585","LU1035773651.USD","LU1066053197.SGD","LU1917777945.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","SG9999015341.SGD","LU0234570918.USD","IE00BKVL7J92.USD","LU2360032135.SGD","IE00BLSP4239.USD","LU0114720955.EUR","LU2106854487.HKD","BK4533","BK4588","LU0889565916.HKD","LU1989772840.SGD","LU1674673691.USD","LU2023250504.SGD","LU2112291526.USD","LU0122379950.USD","LU1037948541.HKD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU0098860793.USD","LU1061106388.HKD","LU0289739699.SGD","LU0130517989.USD","IE00B19Z3581.USD","LU1116320737.USD","IE00BLSP4452.SGD","SG9999015978.USD","SGXZ57979304.SGD","BK4583","LU1974910355.USD","LU1989771016.USD","LU0985320562.USD","LU0823416689.USD","SG9999014567.USD","LU0859254822.USD","IE00BBT3K403.USD","SG9999002232.USD","LU0058720904.USD","LU1934455863.HKD","BK4534","LU1934455194.USD","LU0130102774.USD","LU2125909247.SGD","LU1023059063.AUD","SG9999015952.SGD","LU2087621335.USD","LU0238689110.USD","LU1839511570.USD","IE00B1BXHZ80.USD","GILD","LU2361044865.SGD","SG9999014559.SGD","LU1929549753.HKD","IE0009355771.USD","LU1934455277.USD","LU2357627491.SGD","LU1291159041.SGD","LU0234572021.USD","LU0320765646.SGD","LU1571399168.USD","LU2089984988.USD","BK4568","IE00BSNM7G36.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","LU1069347547.HKD","LU0109394709.USD","BK4566","LU2324357040.USD","LU2361044949.HKD","LU2361045086.USD","BK4007","IE00B7SZLL34.SGD","SG9999015945.SGD","MRK","LU0203345920.USD","LU2461242641.AUD","LU0942090050.USD","LU2125154935.USD","LU0070302665.USD","LU1116320901.HKD","IE0002141913.USD","LU0965509283.SGD","IE0002270589.USD","LU0882574055.USD","LU2491049909.HKD","LU0868494708.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU2125154778.USD","SG9999001176.USD","LU1037948897.HKD","LU1674673428.USD","LU1201861249.SGD","LU1430594728.SGD","LU2491050154.USD","LU0211331839.USD","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197062628","title":"吉利德科学宣布终止Trodelvy联合Keytruda的III期Keynote-D46/Evoke-03研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1197062628","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197062628?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:31","pubTimestamp":1780950708,"startTime":"0","endTime":"0","summary":"吉利德科学已决定终止其III期临床试验Keynote-D46/Evoke-03。该研究旨在评估其药物Trodelvy与默沙东的Keytruda联合用药方案。\n此项研究的终止意味着该联合疗法的开发进程已告一段落。吉利德科学未在本次公告中披露终止该研究的详细原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014542.SGD","LU2112291526.USD","IE00BBT3K403.USD","LU0130102774.USD","IE000M9KFDE8.USD","BK4139","LU1116320901.HKD","LU1983299246.USD","BK4534","LU1934455194.USD","LU2468319806.SGD","SG9999014559.SGD","IE00B4R5TH58.HKD","BK4568","IE00BZ1G4Q59.USD","LU0208291251.USD","IE00B19Z3581.USD","SG9999002224.SGD","LU1934455277.USD","BK4583","LU0265550359.USD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU1674673691.USD","IE0002141913.USD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1989772923.USD","LU2125154778.USD","SG9999001176.USD","IE00BKVL7J92.USD","LU1035773651.USD","LU0106261372.USD","LU0265550946.USD","LU2089984988.USD","MRK","LU0965508806.USD","LU1571399168.USD","LU2125909593.SGD","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU2361045086.USD","LU0122379950.USD","IE00BN8TJ469.HKD","LU1430594728.SGD","LU0965509283.SGD","LU2125909247.SGD","LU0823416689.USD","LU0861579265.USD","LU0109394709.USD","LU0098860793.USD","LU2361044865.SGD","LU0980610538.SGD","LU0203345920.USD","LU1066051498.USD","SG9999013999.USD","SG9999014567.USD","BK4578","LU1023059063.AUD","LU2433249047.HKD","LU2491050154.USD","LU0648001328.SGD","LU0882574055.USD","LU1941712264.USD","LU1989772840.SGD","IE00BLSP4239.USD","LU1093756168.USD","LU1201861249.SGD","LU0859254822.USD","SG9999015341.SGD","LU1585245621.USD","LU1057294990.SGD","LU0965509010.AUD","LU1037948541.HKD","LU2491050071.SGD","LU2491049909.HKD","LU2461242641.AUD","LU1291159041.SGD","LU2357627491.SGD","LU0477156953.USD","LU1699723380.USD","LU0432979614.USD","LU1674673428.USD","LU0965509101.SGD","SG9999014575.USD","LU2360032135.SGD","LU0868494708.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU0130517989.USD","BK4007","LU0234570918.USD","IE00B3T34201.USD","IE00BFTCPJ56.SGD","LU0320765646.SGD","LU0266013472.USD","LU2023250504.SGD","IE00B7SZLL34.SGD","LU1116320737.USD","LU1923622614.USD","LU1934455863.HKD","BK4559","LU1778281490.HKD","LU1917777945.USD","LU1929549753.HKD","SG9999015986.USD","BK4588","BK4516","LU1037948897.HKD","IE0009355771.USD","LU2106854487.HKD","LU1066053197.SGD","IE00B1BXHZ80.USD","LU0006306889.USD","LU2125154935.USD","LU0211331839.USD","LU0985320562.USD","BK4533","LU2023250843.SGD","SG9999002232.USD","LU0238689110.USD","BK4585","IE00BJT1NW94.SGD","IE0002270589.USD","SG9999015952.SGD","LU1066051225.USD","SG9999015358.SGD","GILD","LU0058720904.USD","LU0320765489.SGD","LU1162221912.USD","BK4566","LU1839511570.USD","SGXZ57979304.SGD","SG9999001440.SGD","LU0889565916.HKD","LU1974910355.USD","BK4550","LU1069347547.HKD","LU1989771016.USD","LU2087621335.USD","SG9999015945.SGD","IE00B2B36J28.USD","BK4532","SG9999015978.USD","LU0868494617.USD","LU0070302665.USD","LU0203347892.USD","LU1941712348.USD","LU2361044949.HKD","SG9999001176.SGD","LU0114720955.EUR","LU0942090050.USD","LU0289739699.SGD","LU1066051811.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641103919","title":"默沙东欣瑞来重磅上市，填补针对肺动脉高压根源治疗空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2641103919","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641103919?lang=zh_cn&edition=full","pubTime":"2026-06-08 12:10","pubTimestamp":1780891811,"startTime":"0","endTime":"0","summary":"默沙东今天宣布，全球首个针对肺动脉高压核心病理机制的全人源生物制剂欣瑞来（注射用索特西普）在中国境内上市，用于治疗世界卫生组织功能分级（WHOFC）Ⅱ-Ⅲ级的肺动脉高压（PAH，WHO第1组）成年患者，填补了针对PAH疾病根源的治疗空白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763195321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1934455863.HKD","LU0265550359.USD","LU2125154935.USD","IE00BN8TJ469.HKD","LU0432979614.USD","LU1162221912.USD","SG9999013999.USD","LU1989772923.USD","LU1057294990.SGD","LU1116320737.USD","SG9999014542.SGD","LU1571399168.USD","IE0009355771.USD","LU0208291251.USD","LU2468319806.SGD","LU0859254822.USD","LU1974910355.USD","LU0861579265.USD","LU0868494708.USD","IE00B4R5TH58.HKD","LU0130517989.USD","LU1699723380.USD","LU2089984988.USD","LU2112291526.USD","SG9999015341.SGD","LU1989772840.SGD","LU1061106388.HKD","LU0965508806.USD","LU0477156953.USD","LU1934455277.USD","LU1983299246.USD","LU0942090050.USD","LU2361044949.HKD","BK4007","BK4534","IE00BJJMRZ35.SGD","LU1941712264.USD","LU0122379950.USD","BK4588","LU0070302665.USD","LU0098860793.USD","LU0965509101.SGD","LU0130102774.USD","LU1037948541.HKD","SG9999014575.USD","SG9999014559.SGD","LU0211331839.USD","LU0106261372.USD","LU2023250843.SGD","LU0648001328.SGD","LU2491050071.SGD","LU1035773651.USD","LU0320765646.SGD","LU2357627491.SGD","LU0265550946.USD","BK4516","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU1037948897.HKD","SG9999015358.SGD","LU2125154778.USD","IE00B1BXHZ80.USD","LU0985320562.USD","SG9999001176.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU0266013472.USD","LU0203345920.USD","LU2491049909.HKD","SG9999002224.SGD","LU0965509010.AUD","LU1923622614.USD","LU2360032135.SGD","LU1934455194.USD","LU1066053197.SGD","SG9999014567.USD","LU2361044865.SGD","LU0238689110.USD","LU2361045086.USD","IE00BLSP4239.USD","LU1066051498.USD","MRK","LU1917777945.USD","LU1066051225.USD","SG9999001440.SGD","LU0058720904.USD","BK4550","BK4559","LU0289739699.SGD","LU0234572021.USD","LU2433249047.HKD","BK4533","IE00BLSP4452.SGD","LU2125909247.SGD","IE00B2B36J28.USD","LU1116320901.HKD","IE00BFTCPJ56.SGD","LU2023250504.SGD","LU1093756325.SGD","LU1069347547.HKD","LU1201861249.SGD","SGXZ57979304.SGD","LU0006306889.USD","IE0002141913.USD","LU1989771016.USD","LU2125909593.SGD","IE000M9KFDE8.USD","LU1585245621.USD","LU2491050154.USD","LU0868494617.USD","BK4585","LU0980610538.SGD","SG9999001176.SGD","LU1929549753.HKD","LU1941712348.USD","LU1066051811.HKD","SG9999002232.USD","LU2461242641.AUD","LU2324357040.USD","LU1430594728.SGD","LU1023059063.AUD","LU0203347892.USD","LU1291159041.SGD","LU0965509283.SGD","LU0320765489.SGD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159254796","title":"异动解读｜默沙东盘中上涨3.44%，制药板块整体反弹叠加HIV新药获中国优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1159254796","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159254796?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:14","pubTimestamp":1780582499,"startTime":"0","endTime":"0","summary":"6月4日，默沙东盘中上涨3.44%，报119.41美元/股，成交额2.04亿美元。消息面上，默沙东HIV-1新药多拉韦林伊拉曲韦片近日被中国CDE拟纳入优先审评，该药已于今年3月和4月分别在日本和美国获批上市，III期临床数据显示其非劣效于现有标准方案。此外，默沙东近期还与多家中国本土药企签署肿瘤领域合作协议，持续扩展在研管线布局。本次上涨或受板块情绪回暖及多重利好共振推动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170791258","title":"Apotex推出西格列汀片及西格列汀盐酸二甲双胍片，符合180天共享独占期资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1170791258","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170791258?lang=zh_cn&edition=full","pubTime":"2026-06-03 21:02","pubTimestamp":1780491743,"startTime":"0","endTime":"0","summary":"Apotex公司已正式推出西格列汀片以及西格列汀与盐酸二甲双胍的复方片剂。根据相关法规，这两款仿制药产品有资格获得180天的市场共享独占期。这一独占期安排意味着，在特定条件下，Apotex作为首仿药申请者，可在180天内与原创药企共同分享市场，而无须立即面对其他仿制药的完全竞争。此次仿制药的上市，预计将为糖尿病患者提供更多治疗选择，并可能通过市场竞争影响药品定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU1941712348.USD","LU1037948541.HKD","SG9999001440.SGD","LU0098860793.USD","SGXZ57979304.SGD","LU1917777945.USD","LU1989772923.USD","LU1934455863.HKD","LU0289739699.SGD","LU1201861249.SGD","LU1934455277.USD","SG9999014559.SGD","LU1941712264.USD","IE00BLSP4239.USD","LU1066051498.USD","LU0965508806.USD","LU1934455194.USD","LU0942090050.USD","LU0965509010.AUD","IE00BSNM7G36.USD","LU0320765489.SGD","LU0861579265.USD","BK4007","LU1923622614.USD","LU1983299246.USD","IE00B1BXHZ80.USD","SG9999014575.USD","LU0058720904.USD","LU1023059063.AUD","IE00BLSP4452.SGD","BK4516","LU0122379950.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4533","LU1061106388.HKD","IE0009355771.USD","LU2112291526.USD","SG9999014567.USD","LU0106261372.USD","LU0203345920.USD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","SG9999001176.USD","LU2491050071.SGD","IE00BFTCPJ56.SGD","LU0980610538.SGD","SG9999015341.SGD","LU2125154935.USD","BK4585","LU1162221912.USD","LU2433249047.HKD","LU0868494708.USD","LU1066051225.USD","SG9999002232.USD","IE00B2B36J28.USD","LU2125909247.SGD","LU0211331839.USD","LU0432979614.USD","LU2125909593.SGD","LU2023250504.SGD","LU0006306889.USD","LU2461242641.AUD","LU0130517989.USD","LU0203347892.USD","LU0208291251.USD","LU0130102774.USD","LU1571399168.USD","LU1699723380.USD","IE00BBT3K403.USD","LU0266013472.USD","LU0985320562.USD","LU2491050154.USD","SG9999001176.SGD","LU2468319806.SGD","BK4550","LU2361045086.USD","LU2023250843.SGD","LU0070302665.USD","LU2360032135.SGD","LU1035773651.USD","LU0648001328.SGD","LU0965509283.SGD","LU1116320901.HKD","LU2361044865.SGD","BK4534","LU1291159041.SGD","LU0234572021.USD","LU0320765646.SGD","LU1430594728.SGD","LU2491049909.HKD","LU2357627491.SGD","LU1066051811.HKD","LU1116320737.USD","LU2089984988.USD","BK4588","LU2361044949.HKD","SG9999014542.SGD","IE00B4R5TH58.HKD","LU0859254822.USD","SG9999002224.SGD","LU1069347547.HKD","IE0002141913.USD","LU0265550946.USD","IE00BN8TJ469.HKD","MRK","LU1093756168.USD","LU0965509101.SGD","LU1989771016.USD","SG9999013999.USD","LU0868494617.USD","LU1093756325.SGD","LU2125154778.USD","LU2324357040.USD","LU2106854487.HKD","LU1066053197.SGD","SG9999015358.SGD","BK4559","LU1929549753.HKD","LU0238689110.USD","LU1037948897.HKD","LU0477156953.USD","LU0265550359.USD","LU1974910355.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":0.0385},{"period":"1month","weight":-0.023},{"period":"3month","weight":0.0019},{"period":"6month","weight":0.1235},{"period":"1year","weight":0.492},{"period":"ytd","weight":0.1362}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.1169},{"period":"6month","weight":0.0626},{"period":"1year","weight":0.2223},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.565217,"avgChangeRate":0.010352},{"month":2,"riseRate":0.456522,"avgChangeRate":0.000847},{"month":3,"riseRate":0.608696,"avgChangeRate":-0.003426},{"month":4,"riseRate":0.595745,"avgChangeRate":0.014758},{"month":5,"riseRate":0.638298,"avgChangeRate":0.017693},{"month":6,"riseRate":0.531915,"avgChangeRate":0.012911},{"month":7,"riseRate":0.478261,"avgChangeRate":0.003083},{"month":8,"riseRate":0.5,"avgChangeRate":0.00331},{"month":9,"riseRate":0.521739,"avgChangeRate":-0.006239},{"month":10,"riseRate":0.543478,"avgChangeRate":0.018718},{"month":11,"riseRate":0.717391,"avgChangeRate":0.032717},{"month":12,"riseRate":0.608696,"avgChangeRate":0.013778}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}